Sanofi (ADR) (NYSE:SNY)

Buffet

Key Changes in Warren Buffett and Berkshire Hathaway Stock Holdings

Warren Buffett and Berkshire Hathaway Inc. (NYSE: BRK-A) have released the official equity holdings of Berkshire Hathaway as of June 30, 2015. It has been the case for years now ...
Read Full Story »
Biotechnology word cloud

Have Analysts Fully Priced in Praluent to Regeneron?

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NYSE: SNY) announced last Friday that the U.S. Food and Drug Administration (FDA) approved Praluent (alirocumab) Injection. Praluent is indicated as an adjunct ...
Read Full Story »
Prescription drugs

Are Cancer Drugs Becoming Too Costly for Their Effectiveness?

When the American Society of Clinical Oncology (ASCO) decided to create a rating scale for cancer drugs, it certainly must have expected to get some pushback. The group’s initial version ...
Read Full Story »
145922793

New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels

This coming week is likely to be a serious one in the fight against cholesterol. This covers a new class of drugs in the PCSK9 classification, and FDA panels are ...
Read Full Story »
investing

Has MannKind Stock Finally Bottomed Out?

MannKind Corp. (NASDAQ: MNKD) is just about as controversial of a company as you will find today when it comes to biotech and pharma. Its recently launched Afrezza has had ...
Read Full Story »
penny stack

What to Make of MannKind Earnings

MannKind Corp. (NASDAQ: MNKD) reported its first-quarter financial results after the markets closed Thursday. The biotech company had a net loss of $0.08 in earnings per share (EPS) and no ...
Read Full Story »
Wall Street

Top Analyst Upgrades and Downgrades: Coach, Garmin, Intelsat, Potbelly, SolarCity, Valero and More

Stocks were again seeking direction on Thursday morning after recently hitting new highs again. If there is one trend that keeps being proven it is that investors will buy stocks ...
Read Full Story »
Buffet

Meet the 2015 Warren Buffett and Berkshire Hathaway Stocks

Berkshire Hathaway Inc. (NYSE: BRK-A) has made its quarterly filing with the Securities & Exchange Commission for its holdings as of December 31, 2014. For all practical purposes, this filing is ...
Read Full Story »
fda_logo

5 Critical Biotech Drug Dates and Events for December

At least five upcoming dates could be big days in December, for better or worse, for individual biotech stocks. These events refer to reviews and decisions by the U.S. Food ...
Read Full Story »
Volkswagen Golf 2015

Companies Spending the Most on R&D

For the third consecutive year, the company spending the most on research and development (R&D) was Germany’s Volkswagen. The automaker’s 2014 R&D spending will total $13.5 billion, just ahead of ...
Read Full Story »
Buffet

Significant Changes in Buffett and Berkshire Hathaway Holdings

Berkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2014. Warren Buffett’s portfolio has recently undergone some radical changes on the surface, some of ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Alibaba, Amgen, Cliffs, Michael Kors, Sanofi, Yahoo! and More

Stocks are looking for direction on Wednesday with mixed indexes, but that is after another massive rally on Tuesday that took the DJIA back over 17,000 again. Earnings season is ...
Read Full Story »
Buffet

Major Portfolio Changes for Warren Buffett and Berkshire Hathaway

Berkshire Hathaway Inc. (NYSE: BRK-A) released its public equity holdings as of June 30, 2014. Warren Buffett's different portfolio holdings have not been changing much of late, but it turns ...
Read Full Story »
Stock Split Image

What the Market Is Telling MannKind (Updated)

MannKind Corp. (NASDAQ: MNKD) was supposed to be a huge winner on this week's news that Sanofi (NYSE: SNY) will become its global partner for its inhalable insulin Afrezza. There has ...
Read Full Story »
76764023

MannKind Secures Future of Afrezza in Major Sanofi Deal

MannKind Corp. (NASDAQ: MNKD) was supposed to be in the news for its earnings report. Instead, we got news of its strategy on how to get its Afrezza inhalable insulin ...
Read Full Story »